Canadians could get more affordable version of Ozempic in early 2026
If I need something, I would get it from Empower, Lipshultz said, estimating that the prices can be roughly 80% cheaper than brand-name drugs
To minimize risk, we carry only non-controlled substances
Not everyone tolerates GLP-1 well, and personalized assessmentinformed by your biomarker and genetic datahelps determine whether continued treatment is appropriate or whether a different approach better suits your physiology
Dont wait any longer to achieve the look youve always dreamed of and the confidence you deserve
Experts increasingly advocate aligning safety expectations for high-risk probiotic products (e.g., LBPs) with those applied to other complex biologicals, including systematic genomic characterization, standardized adverse-event reporting, and structured post-market surveillance, while avoiding unnecessarily stricter requirements than for comparable biologic therapies (525)